NASDAQ
Adverum Biotechnologies, Inc. (ADVM) has a price/sales ratio of 92.38x as of Friday, May 22, 2026. This represents a 4.95% increase compared to its 12-month average of 88.02x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.